We report data on the number of Epstein-Barr virus (EBV) particles required to detect virus binding to target cells (Raji or BJA-B) by means of membrane immunofluorescence (MIF). After determining the optimum conditions for the MIF assay the following aspects of EBV-lymphoid cell interactions were examined: (i) binding of two different strains of EBV to various types of human lymphoid cell lines, (ii) expression of receptors for both EBV and complement on these lines and (iii) induction of EBV-induced nuclear antigen (EBNA) in the different target cells used. The results showed that a minimum of about 2.7 × 10 3 enveloped virus particles/cell were required for an optimum visualization of EBV binding to the target cells tested, and that a lymphoid cell may bear receptors for one prototype strain of EBV but not for the other. A number of cell lines, particularly those of T and null type which express EBV receptors, did not synthesize EBNA, thus indicating that these lines were resistant to EBV infection. Several of these lines, although expressing cell surface EBV receptors, lacked complement receptors.
INTRODUCTION
The presence of virus receptors on a cell is not necessarily related to the permissiveness of that cell to virus replication, since following virus adsorption to the target cell surface, no virus-induced intracellular events appear to occur in these cells (Lonberg-Holm & Philipson, 1974; Menezes et al., , 1978 gobb & Martin, 1972) .
Human B lymphocytes, but not T lymphocytes, normally bear receptors for Epstein-Barr virus (EBV) (Jondal & Klein, 1973) , and it has been suggested that the presence of EBV receptors on the cell surface may be considered as a marker of human B lymphocytes (Aiuti et al., 1975; Greaves et al., 1975) and more specifically B cells having surface-bound IgM (Katsuki et al., 1977) . On the other hand, data now available on the markers of EBV-transformed lymphoid cell lines infer that EBV may also transform cells other than typical B lymphocytes (Menezes et al., 1976; Robinson et al., 1977) . Moreover, one line of T cell origin (Molt-4; Minowada et al., 1972) was found to have a unique interaction with EBV. Although Molt-4 cells bear surface receptors for EBV, virus penetration is not detected after adding EBV . Therefore, it was possible that other EBV genome-negative cell lines, particularly lines of T cell type or those derived from some undifferentiated cells or stem cells from patients with acute lymphoblastic leukaemia (ALL) or lymphomas, may also bear receptors for EBV and that these lines would represent ~" a unique tool to learn more about EBV-cell interactions. We therefore established the optimum conditions for detecting virus receptors using the membrane immunofluorescence (MIF) assay. These optimum conditions were then utilized to detect virus receptors on cell lines of either B, T or null type. The following aspects were explored: (i) expression of receptors for both lymphocyte-transforming (B95-8) and non-transforming (P3HR-1) strains of EBV, (ii) induction of EBV-related antigens in these cell lines following EBV infection and (iii) the expression of C' receptors using both the sensitive anti-C' MIF method and the standard EAC rosette test (see Methods), since an association between EBV and C' receptors has been reported previously .
METHODS
Cell lines. The various cell lines used for this study, their nature and origin are described in Table 1 . They were cultured at 37 °C in medium RPMI-1640 supplemented with 10% heat-inactivated foetal bovine serum and antibiotics (RPMI-10) as described previously (Patel et al., 1978) . The cultures were fed twice weekly and readjusted to 2 × 105 cells/ml at each feeding.
Virus preparations. Two different lots from each strain of EBV were used for these experiments. Lots B-19 (B95-8-EBV) and P-6 (P3HR-1-EBV) were prepared in our laboratory essentially as described (Menezes et al., 1975a) . Briefly, virus-containing culture fluids from the two producer lines B95-8 and P3HR-1 were clarified by low-speed centrifugation and Millipore (0.45 pro) filtration. The virus was then pelleted at 45000 g for 90 rain and resuspended in medium RPMI-10 to obtain 50-to 100-fold concentrated virus preparations. These virus preparations were dispersed in small vials and stored temporarily (up to 2 weeks) at 3 to 4 °C or at -85 °C until used. They were also checked by electron Quantification of virus particles by electron microscopy. The number of virus particles in a given preparation was quantified as described by Monroe & Brandt (1970) . Briefly, 0.1 ml of the virus preparation was mixed with an equal volume of a known concentration of latex particles (109.9 nm, Dow Diagnostics, Indianapolis, Ind., U.S.A.) in suspension. A carbon-coated grid was then allowed to float on a drop of this virus-latex mixture for 1 rain. Excess fluid was then drained and the grid stained with 2% phosphotungstic acid before examination at a magnification of x 30000 using a Philips 201 electron microscope. The results for the number of particles needed per cell for MIF were expressed in terms of enveloped particles, as it has been shown that only enveloped particles attach to the susceptible target cell in the infection process (Seigneurin et al., 1977) .
Detection of receptors for EBV. The binding of EBV to target cells was detected by membrane immunofluorescence as described before . Virus preparations were first titrated on indicator EBV receptor-positive Raji and BJA-B cells and the virus dilution giving the highest percentage of membrane fluorescence with no appreciable background was then used throughout. However, for cell lines which gave negative results under these conditions (see below), experiments were repeated using undiluted virus preparations. For the EBV binding test, 5 × 105 lymphoid ceils were first sedimented by low-speed centrifugation and, after discarding the supernatant, 0.1 ml EBV suspension was added to the pellet. The cells were then gently dispersed and the mixture incubated at 4 °C for 45 min. The cells were then washed twice in cold phosphate-buffered saline (PBS, pH 7.2) and stained by indirect membrane immunofluorescence (MIF) to detect bound virus. In the staining procedure washed cells were incubated with 0.2 ml of 1:2 dilution of serum (JJ) from a healthy EBV-seropositive individual [containing EBVneutralizing antibody (Ab), as well as antibodies directed against EBV-induced membrane antigen, EBNA and virus capsid antigen (VCA)] at 4 °C for 45 min. After two washings the cells were incubated at 4 °C with 0-1 ml of a 1/30 dilution of fluorescein isothiocyanateconjugated goat anti-human IgG (7-chain specific, lot no. 2257 V00 3A1 from Hyland Laboratories, Calif., U.S.A.). Cells were washed three times, resuspended in 0.05 ml of a 1:1 mixture of PBS :glycerol and examined for MIF under a microscope with u.v. illumination. All the washings referred to above were carried out in cold PBS. The following controls were included: (i) cells + conjugate; (ii) cells + EBV + conjugate; (iii) cells + JJ serum + conjugate; (iv) cells + EBV + JJ serum; (v) cells + EBV + EBV-0 serum (from a healthy donor with no detectable anti-EBV antibody) + conjugate; (vi) cells + fresh growth medium + JJ serum + conjugate. No MIF-positive cells were detected in these controls. Moreover, in this assay, by replacing EBV preparation with neutralized EBV no detectable MIF was observed (see Table 2 ). In positive samples, 200 live cells were counted to determine the percentage of MIF-positive cells. It is noteworthy that we chose the indirect MIF with JJ serum to detect EBV binding to cell surface as it gave more intense fluorescence than direct MIF using fluorescein-conjugated anti-EBV reference immunoglobulin ( 
* A 0.1 ml amount of the virus dilution was mixed with equal volumes of a 1 : 2 dilution of anti-EBV serum (JJ) and incubated at 37 °C for 1 h. Density gradient-purified P3HR-1 virus preparation (lot 21-4, see Methods) was used in these experiments.
t The figures given in this table represent means of two separate experiments. ~: A subjective assessment of the intensity of fluorescence from 'very bright' (++++) to negative (-) was performed.
§ See Fig. 1 for additional information.
1976). Moreover, the fact that the target cells used do not react with anti-y-chain conjugate made this indirect test suitable for the present study. and to activate it through the indirect pathway (Yefenof et aL, 1977) . The procedure used is essentially that described earlier . A pellet of washed 1 x 106 cells was resuspended in 0-2 ml of a 1/5 dilution of fresh human serum from an EBV-seronegative healthy donor and the mixture incubated for 30 rain at 37 °C. Subsequently, the cells were washed twice and incubated for 30 min at 4 °C in 0. 
Detection of complement receptors

Detection of EBV-determined nuclear antigen (EBNA).
Infected cells were harvested on days 1, 2, 3 and 4 post-infection. Smears were made, air-dried, fixed and stained for EBNA using the two-step anti-complement immunofluorescence assay (Menezes et al., 1976) . EBNA is the first and earliest detectable intracellular antigen produced in an EBVinfected and susceptible target cell (Menezes et al., 1978b) ; hence, other EBV-associated antigens (EA, VCA) were not investigated in the present study.
RESULTS
Quantification of virus particles required for MIF receptor assay
To establish the optimum conditions for the MIF assay we first determined, by quantitative electron microscopy, the number of EBV particles in preparations which had been concentrated and purified by density-gradient centrifugation. These were then used to determine the number of particles required to produce different degrees of MIF. Table 2 When the MIF assay was performed using a virus preparation containing a lower percentage of enveloped particles (e.g. 20% in lot 3373-22) the m.o.i, required in terms of enveloped particles was comparable to the results obtained with the above P3HR-1-EBV preparation (data not shown). This observation confirms that only enveloped particles bind to EBV receptor-positive target cells as previously reported (Seigneurin et al., 1977) .
In addition, the results given in Table 2 show that the percentage of MIF-positive cells obtained in these experiments is proportional to the EA-or EBNA-inducing titres (in Raji and BJA-B cells respectively) of the virus preparations used. Moreover, Table 2 also shows that the MIF and antigen induction (EA or EBNA) is EBV specific, as the neutralization with anti-EBV serum (J J) significantly decreased the percentage of MIF and EA or EBNA titres. Treatment of EBV preparations with EBV antibody-negative serum had no effect on MIF or antigen induction (data not shown). Table 3 shows the expression of EBV receptors by lymphoid cells of different origin. The null cell lines Nall-1, Reh and Nalm-6 did not express receptors for the B95-8 EBV strain, while 65 to 91% of the cells did bind P3HR-1 EBV. Other null cell fines Nalm-1, Nalm-12, Nalm-13 and Nalm-16 had considerably less cells expressing receptors for the B95-8 EBV strain than for the P3HR-1 EBV strain. The cell lines K-562 and 1301 lacked receptors for both B95-8 and P3HR-1 strains of EBV. With regard to B cell lines, all except U698M, bound both strains of EBV. No distinct pattern of strain-specific EBV receptor MIF on these B cells was discernible. U698M was the only B cell line that showed strain-specific receptor differences as it bound P3HR-1 EBV and not B95-8. The percentage of cells of T origin expressing receptors for the B95-8 strain was consistently higher than that with receptors for the P3HR-1 EBV strain.
Receptors for EB V on lymphoid cells
Relationship between the presence of EB V receptors on different cell lines and the susceptibility of these lines to virus infection
The data indicate that EBV replication or antigen induction does not necessarily occur in all the lines which have binding sites for this virus (Table 3 ). This is substantiated by the observations that the lines Nalm-1, Nalm-6, Nalm-12, Nalm-13, Nail-l, Reh, Molt-3, Molt-4, CCRF-HSB-2, RPMI-8402, U698M and RPMI-8226 express receptors for at least one strain of EBV but are not permissive to EBV infection, as judged by the lack of EBNA induction.
Qualitative differences in MIF
In addition to quantitative differences between EBV receptor-positive cells, reproducible qualitative differences were also observed in terms of the MIF pattern in various lines tested. Interestingly, even under optimum experimental conditions, EBV genome-negative cell lines expressing virus receptors showed predominantly a finely dotted fluorescence on their cell surface, sometimes in a ring pattern (Fig. 1 b) . EBV genome-positive cells, on the other hand, showed a bright fluorescence in continuous to slightly dotted rings (Fig. la) . 
Comparative expression of receptors for EBV and complement in different types of human lymphoid cell lines
A comparison between the expression of EBV and complement receptors was carried out using different lymphoid cell lines (Table 3 ). The data indicate that both receptors are not always expressed on the same cell. The null cell lines (Nail-I, Reh, Nalm-6, Nalm-12 and Nalm-13) have EBV receptors (up to 92% of a cell population) but have no or very few C' receptor-bearing cells. These findings suggest that in these EBV genome-negative cell lines, there is not a close relationship between EBV and C' receptor expressions, such as the one reported with other cell systems Einhorn et al., 1978) .
All lines of T cell origin, except CCRF-HSB-2, had a significant percentage of their cells bearing surface receptors for both C' and EBV. Similarly, all B cell lines, except U698M, expressed receptors for C' on their surface. However, the BJA-B and Ball-1 lines showed a low percentage (5 to 26%) of C' receptor-bearing cells while the percentage of EBV receptor-bearing cells was high (75 to 100%).
D I S C U S S I O N
The present study was carried out to learn more about EBV interaction with human lymphoid cell subpopulations, and used established lymphoid cell lines, instead of freshly isolated lymphocyte preparations. This approach allowed us to employ more reproducible experimental conditions and monoclonal lymphoid lines with characteristic markers of B, T or null cells.
In the present study for the detection of EBV binding to its target cells, we preferred to use the MIF procedure rather than an adsorption assay (Sairenji & Hinuma, 1973) as the latter only measures EBV infectivity of the unbound, residual virus in a given preparation and disregards the non-infectious or defective particles bound to target cells. As with other human herpesviruses, EBV preparations may contain infectious virions mixed with defective or non-infectious particles. These non-infectious particles will certainly compete with the 8 P. PATEL AND J. MENEZES infectious ones and thus make the adsorption assay less sensitive than MIF, particularly for cells bearing few EBV receptors.
One of the main implications of our results is that the presence of EBV receptors on a cell does not necessarily mean that the cell is permissive for the replication of that virus. This phenomenon has been observed mainly in lines of T cell origin and of non-T-non-B (null) origin, while most cell lines of B cell origin are susceptible to EBV infection as manifested by EBNA synthesis. The significance of this observation may be that in vivo, EBV transforms and/or replicates only in cells of B lineage. The presence of EBV receptors on null and T cells could imply that these cells may not necessarily be involved in EBV replication but rather involved in some immunoregulatory functions to suppress or control EBV-infected or EBV-transformed cells. Such interactions with T or null cells may also be responsible for the depressed cell-mediated immunity (Haider et al., 1973) , depressed response in vitro to PHA (Mangi et aL, 1974) and allogeneic lymphocytes (Twomey, 1974) of cells obtained from patients with infectious mononucleosis following infection with EBV (Henle & Henle, 1972) . Another possibility, that the EBV genome does indeed get into T or null cells but is completely repressed, cannot be disregarded and sensitive molecular hybridization techniques and additional electron microscopy studies may be helpful in this regard. Electron microscopy studies have shown that, although EBV adsorbs to Molt-4 cells, virus particles or nucleocapsids cannot be seen in the cells and the virus genome is not expressed . Thus, if one assumes that virus penetration or repression of EBV genetic information is blocked in EBV receptor-positive T and null cells, then B lymphocytes may lack the ability to control EBV infection in this manner. This, in turn, may explain why EBV genome-carrying lymphomas or cell lines are primarily of B cell type.
The conclusion that some cells possess receptors specific for different EBV strains is based on the observation that most null cell lines appear to bind EBV of the P3HR-1 strain only, that the percentage of cells bearing receptors for the B95-8 EBV strain in T cell lines is consistently higher than that having P3HR-1 EBV receptors, and that one B cell line (U698M) has receptors only for the P3HR-1 EBV strain.
Several investigators Yefenof et al., 1976; Einhorn et al., 1978) have reported data indicating that the receptors for EBV and complement may represent the same or very closely associated structure, particularly on the B lymphocyte surface. The data obtained in the present investigation do not favour this general concept, since U698M (a B cell line) binds the P3HR-1 strain of EBV but lacks receptors for B95-8 EBV and complement, lit is noteworthy that two contradictory reports on EBV binding to U698M cells have been published (Klein et al., 1974; Jondal et al., 1976) .] Also, most of the null cell lines have EBV receptors but lack receptors for the third component of complement. Our study agrees with Glaser et al. (1977) who showed that epithelial-lymphoma hybrid cells could be infected by EBV but lacked complement receptors, and with Schwaber et aL (1980) who reported that EBV and complement receptors are not associated in lymphocytes from certain patients with agammaglobulinaemia. Furthermore, EBV-immortalized marmoset lymphoid cell lines which have B cell characteristics lack receptors for complement (Robinson et al., 1977; Patel et aL, 1978) . It is also noteworthy that one of the null cell lines used, Reh, which lacks C' receptors has also been found to bear receptors for P3HR-1 EBV by another group of investigators (Rosenfeld et aL, 1977 ) using the rosette technique described by Jondal & Klein (1973) . The possibility that the expression of cellular receptors for EBV may vary or fluctuate in a cell population according to its physiological stage, age of culture or passage number in vitro cannot be disregarded at the present time.
In the course of the present study we were also able to detect qualitative differences in the pattern of MIF on different lymphoid cells. These differences may very likely be due to the density of EBV receptors on the cell surface and this possibility is presently being investi- 
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gated. In this regard, it has been observed that P3HR-1 EBV-converted BJA-B cell lines have a lower concentration of EBV receptors on their surface than the B95-8 EBV-converted lines (Klein et al., 1979) . Furthermore, our experiments indicated that, depending on the cell line used, a minimum of 2.7 x 102 to 2.7 x 103 enveloped particles/cell are necessary for the MIF assay. This variation may reflect differences in the concentration of EBV receptors on the surface of different cells.
In conclusion, the data obtained in the present study indicate that, in addition to B cells, other lymphoid cells of both T and null type may express receptors for EBV. The functional significance of these EBV receptors on T and null cells is presently unknown and is particularly intriguing since EBV does not replicate or induce EBNA. In addition, our data also indicate that there may be EBV strain-specific receptors on the surface of some lymphocytes and the receptors for EBV and complement, even in some cases of B cells, may not always be necessarily associated with each other.
